Cargando…

NK cell markers predict the efficacy of IV immunoglobulins in CIDP

OBJECTIVE: To assess whether IV immunoglobulins (IVIgs) as a first-line treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) have a regulative effect on natural killer (NK) cells that is related to clinical responsiveness to IVIg. METHODS: In a prospective longitudinal study, we co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mausberg, Anne K., Heininger, Maximilian K., Meyer Zu Horste, Gerd, Cordes, Steffen, Fleischer, Michael, Szepanowski, Fabian, Kleinschnitz, Christoph, Hartung, Hans-Peter, Kieseier, Bernd C., Stettner, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577535/ https://www.ncbi.nlm.nih.gov/pubmed/33008921 http://dx.doi.org/10.1212/NXI.0000000000000884

Ejemplares similares

Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology
por: Szepanowski, Fabian, et al.
Publicado: (2021)

Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis
por: Meyer zu Horste, Gerd, et al.
Publicado: (2016)

Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis
por: Mausberg, Anne K., et al.
Publicado: (2018)

Time for a standardized diagnostic response test in patients with chronic inflammatory demyelinating polyradiculoneuropathy?
por: Szepanowski, Fabian, et al.
Publicado: (2023)

Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling
por: Szepanowski, Fabian, et al.
Publicado: (2016)

LPA(1) signaling drives Schwann cell dedifferentiation in experimental autoimmune neuritis
por: Szepanowski, Fabian, et al.
Publicado: (2021)

Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages
por: Mausberg, Anne K., et al.
Publicado: (2011)

FoxP3+ Regulatory T Cells Determine Disease Severity in Rodent Models of Inflammatory Neuropathies
por: Meyer zu Hörste, Gerd, et al.
Publicado: (2014)

High-dose biotin neither fosters remyelination nor stimulates malonyl coenzyme A synthesis in the regenerating nerve
por: Szepanowski, Fabian, et al.
Publicado: (2022)

Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
por: Heming, Michael, et al.
Publicado: (2021)

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide
por: Buerth, Christoph, et al.
Publicado: (2016)

Glyphosate-based herbicide: a risk factor for demyelinating conditions of the peripheral nervous system?
por: Szepanowski, Fabian, et al.
Publicado: (2019)

Severe and long-lasting alteration of albumin redox state by plasmapheresis
por: Boss, Kristina, et al.
Publicado: (2022)

Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009)

Quinpramine Ameliorates Rat Experimental Autoimmune Neuritis and Redistributes MHC Class II Molecules
por: Meyer zu Hörste, Gerd, et al.
Publicado: (2011)

CIDP, myasthenia gravis, and membranous glomerulonephritis – three autoimmune disorders in one patient: a case report
por: Bolz, Saskia, et al.
Publicado: (2018)

Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection
por: Fleischer, Michael, et al.
Publicado: (2021)

Targeting lysophospholipid signaling as a therapeutic approach towards improved peripheral nerve regeneration
por: Szepanowski, Fabian, et al.
Publicado: (2016)

Interleukin-17 impedes Schwann cell-mediated myelination
por: Stettner, Mark, et al.
Publicado: (2014)

Novel pathomechanisms in inflammatory neuropathies
por: Schafflick, David, et al.
Publicado: (2017)

Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy
por: Fleischer, Michael, et al.
Publicado: (2021)

Correction: Promoting Myelination in an In Vitro Mouse Model of the Peripheral Nervous System: The Effect of Wine Ingredients
por: Stettner, Mark, et al.
Publicado: (2013)

Promoting Myelination in an In Vitro Mouse Model of the Peripheral Nerve System: The Effect of Wine Ingredients
por: Stettner, Mark, et al.
Publicado: (2013)

The Cost Effectiveness of Immunoglobulin vs. Hematopoietic Stem Cell Transplantation for CIDP
por: Burt, Richard K., et al.
Publicado: (2021)

Focus on LPA signaling: a promising therapeutic target to foster regeneration in immune-mediated neuropathies
por: Szepanowski, Fabian, et al.
Publicado: (2023)

Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients
por: Fleischer, Michael, et al.
Publicado: (2022)

Retrospective correlation analysis of plasma Immunoglobulin G and clinical performance in CIDP
por: Markvardsen, Lars Kjøbsted, et al.
Publicado: (2019)

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study
por: van Schaik, Ivo N., et al.
Publicado: (2019)

Corneal Confocal Microscopy Demonstrates Corneal Nerve Loss in Patients With Trigeminal Neuralgia
por: Lee, John-Ih, et al.
Publicado: (2020)

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes
por: Feng, Yuan, et al.
Publicado: (2020)

Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II
por: Hartlehnert, Maike, et al.
Publicado: (2017)

The Misdiagnosis of CIDP: A Review
por: Allen, Jeffrey A.
Publicado: (2020)

Treatment Approaches for Atypical CIDP
por: Menon, Deepak, et al.
Publicado: (2021)

Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity
por: Wolbert, Jolien, et al.
Publicado: (2020)

Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG Oligonucleotide
por: Smolianov, Vsevolod, et al.
Publicado: (2011)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

CIDP mimics: a case series
por: Moshe-Lilie, Orly, et al.
Publicado: (2021)

Isoniazid-induced polyneuropathy in a tuberculosis patient – implication for individual risk stratification with genotyping?
por: Stettner, Mark, et al.
Publicado: (2015)

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
por: Blackhouse, Gord, et al.
Publicado: (2010)

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
por: Merkies, Ingemar S.J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gitkfrku6bgj7qfmv4gofvq3g2